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A B S T R A C T   
Background: Patients diagnosed with Alcohol Use Disorder (AUD) present an increased risk for experiencing 
severe internalizing and externalizing symptoms. Involvement in twelve-step based treatment programs, such as 
the Minnesota Model (MM), can contribute to improvement of an individual’s psychopathological symptom 
profile. The present study’s main objective was to examine profiles and change trajectories of psychopathological 
symptoms of AUD subgroups during an eight-week long period of MM treatment attendance. 
Method: Inpatients with AUD (N = 303) who attended MM treatment programs participated in the present 
study. Latent Class Growth Analysis (LCGA) was used to evaluate the psychopathological symptom change 
trajectories assessed by using the Brief Symptom Inventory (BSI). Multiple comparisons and multinomial logistic 
regression were performed to validate the subgroups. 
Results: Three subgroups were identified: low severity (48.5%), moderate severity (35.2%), and high severity 
(16.2%) symptomatic subgroups. The moderate severity class demonstrated the largest effect in terms of 
symptoms decrease. Higher severity classes showed significantly higher rates of harmful alcohol drinking and 
drinking motives. 
Conclusions: The present study identified three severity-based subgroups which indicate that psychopathology 
sits on a spectrum of severity among AUD patients. The findings highlight the associations between AUD and 
internalizing symptoms, negative reinforcement drinking motives, and the symptomatic improvement that can 
occur among those participating in MM treatment programs.   
1. Introduction 
Alcohol use disorder (AUD) is a chronic problem causing significant 
psychological, physical, interpersonal, and social burden among alcohol 
users and their environment. Extensive empirical research suggests that 
AUD frequently co-occurs with diverse or even multiple forms of psy-
chiatric disorders, such as major depressive disorder, panic disorder, 
obsessive-compulsive disorder, generalized anxiety disorder, post- 
traumatic stress disorder, social phobia, or antisocial personality dis-
order (for review, see Bradizza, Stasiewicz, & Paas, 2006). Comorbid 
externalizing and internalizing psychopathology are often associated 
with more severe subtypes of AUD in terms of clinical characteristics 
and prognosis (e.g., higher drinking severity, worse health status;  
Hildebrandt, Epstein, Sysko, & Bux, 2017; Moss, Chen, & Yi, 2010) and 
harmful treatment-related consequences (e.g., higher level of treatment 
drop-out, increased vulnerability of early and long-term relapse after 
treatment; Farren & McElroy, 2010; Krawczyk et al., 2017). Further-
more, some psychopathological symptoms (e.g., depression or anxiety 
symptoms) have an integral role in the pathology of AUD, such as 
progression into more pathological stages of AUD, motivation and 
maintenance of compulsive alcohol use, craving and relapses, or even 
during a period of long-term abstinence. For example, the allostatic 
model assumes that during the progression from early stages (e.g., 
preoccupation with alcohol use, frequent intoxication) to the more se-
vere, compulsive stage of AUD, there is a shift in the motivational 
background of alcohol use from positive reinforcement (i.e., drinking to 
https://doi.org/10.1016/j.abrep.2020.100302 
Received 31 March 2020; Received in revised form 3 August 2020; Accepted 18 August 2020    
⁎ Corresponding author at: Institute of Psychology, Eötvös Loránd University, Izabella utca 46, Budapest H-1064, Hungary. 
E-mail address: horvath.zsolt@ppk.elte.hu (Z. Horváth). 
Addictive Behaviors Reports 12 (2020) 100302
Available online 08 September 2020
2352-8532/ © 2020 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
T
facilitate positive emotions and hedonic states) to negative reinforce-
ment (i.e., drinking to alleviate negative affective states related to 
withdrawal), and function of negative affectivity becomes central due 
to adverse modifications in the reciprocal emotion-regulation and re-
ward-regulation systems (Koob, 2013; Le Moal & Koob, 2007). Another 
possible form of comorbidity is alcohol-induced mental disorders, such 
as mood, anxiety, bipolar and psychotic disorders, where psycho-
pathological symptoms last for 1–6 months following excessive use of 
alcohol (Saunders, 2017). 
Changes in psychopathological symptoms over time among in-
dividuals with AUD have been examined in a large body of existing 
literature. For example, studies using meta-analysis and systematic re-
view have reported that patients with comorbid AUD and psychiatric 
disorders show improvements in depression, anxiety, and post-trau-
matic stress disorder symptoms due to involvement in antidepressant 
pharmacological therapies, cognitive behavioral therapies, and moti-
vational interviewing (Baker, Thornton, Hiles, Hides, & Lubman, 2012; 
Foulds, Adamson, Boden, Williman, & Mulder, 2015; Hobbs, Kushner, 
Lee, Reardon, & Maurer, 2011; Riper et al., 2014; Roberts, Roberts, 
Jones, & Bisson, 2015). Moreover, previous studies have demonstrated 
that participation in structured twelve-step based therapeutic ap-
proaches, such as the Minnesota Model (MM) and the Twelve Step 
Facilitation (TSF) treatment, not only have beneficial impact on 
drinking-related outcomes (e.g., reaching longer periods of abstinence;  
Grønbaek & Nielsen, 2007; Kelly, Humphreys, & Ferri, 2020; Project 
Match Research Group, 1998), but also related to improvements in 
psychopathological-related (e.g., attenuation of depression symptoms) 
outcomes (Andó et al., 2016; Worley, Tate, & Brown, 2012). 
In addition to other analytical approaches (e.g., factor analysis;  
Harford, Yi, Chen, & Grant, 2015), one possible way to examine 
structure and patterns of psychopathological comorbidity among in-
dividuals with AUD is to use person-centered analyses, such as latent 
class or profile analysis (Urbanoski, Kenaszchuk, Veldhuizen, & Rush, 
2015). These methods allow to obtain better understanding on the 
heterogeneity within AUD by distinguishing subgroups of individuals 
where members within each identified class show similar profiles and 
combinations of psychopathological comorbidity. Among individuals 
with AUD either from treatment seeking or general population samples, 
previous studies have identified three to five distinct subgroups based 
on indicator variables assessing co-occurring psychopathological 
symptom levels or disorder presence (Glass, Williams, & Bucholz, 2014; 
Müller et al., 2019; Urbanoski et al., 2015; Villalobos-Gallegos, Marín- 
Navarrete, Roncero, & González-Cantú, 2017; Wallen, Park, Krumlauf, 
& Brooks, 2019). These studies have been conflicting in terms of the 
observed differences between the identified latent classes: quantitative 
(e.g., parallel and severity-based psychopathological symptom profiles;  
Villalobos-Gallegos et al., 2017) and qualitative differences have been 
suggested between the psychopathology-based subgroups (e.g., classes 
with mainly externalizing and internalizing comorbidity; Glass et al., 
2014). 
However, to the best of the authors’ knowledge, no previous study 
has examined how latent classes of AUD change over time or due to 
treatment attendance in terms of co-occurring psychopathological 
symptom levels. Investigation of temporal change patterns of psycho-
pathology-based latent classes might contribute to broaden existing 
knowledge about AUD in two broad aspects. First, it would be possible 
to obtain more detailed understanding on the structure of comorbid 
psychopathology among individuals with AUD. Considering the prin-
ciples of latent class growth analysis (Jung & Wickrama, 2008), it is 
assumed that individuals with AUD might show substantial variability 
how their psychopathological symptom levels change over time and 
different subtypes of AUD might present various trajectories. Therefore, 
comorbid psychopathology-based subgroups might have heterogenous 
characteristics not only in terms of severity (e.g., mild level vs. high 
level of psychopathology) and qualitative aspects (e.g., presence of 
comorbid internalizing vs. externalizing psychopathology) of 
psychopathology, but in temporal patterns as well (e.g., higher degree 
of change vs. resistance of change in the level of psychopathology). 
Based on this approach, clinical prognosis of subgroups of AUD can be 
assessed in terms of comorbid psychopathology (Urbanoski et al., 
2015). 
Second, by identifying comorbid psychopathology-based latent 
classes it is possible to examine how these subgroups of AUD might 
differ in terms of treatment response (Lanza & Rhoades, 2013). Existing 
literature data has suggested that treatment effectiveness of a given 
intervention can vary as a function of membership of latent classes 
which are characterized with different profiles of alcohol misuse and 
internalizing and externalizing psychopathology (Roos, Bowen, & 
Witkiewitz, 2017). However, to the best of the authors’ knowledge, no 
previous study has examined treatment-seeking individuals with AUD 
profile characteristics as well as temporal change patterns of comorbid 
psychopathology-based latent classes during an AUD-related treatment 
participation. Classification participants based on psychopathological 
symptom severity and change profiles can help (i) to identify subgroups 
of AUD to whom a given treatment form can be considered as more 
effective, (ii) to design more individually-customized interventions and 
(iii) to specify in a more in-depth way how comorbid psychopatholo-
gical symptoms alter treatment outcomes (Lanza & Rhoades, 2013; 
Urbanoski et al., 2015; Villalobos-Gallegos et al., 2017). 
The aim of the present study was to examine patterns of severity and 
changes of psychopathological symptoms among subgroups of AUD 
inpatients attending a twelve-step based treatment program. It was 
hypothesized that the psychopathological-based latent classes of AUD 
can be discriminated in terms of symptom severity and temporal change 
patterns (Jung & Wickrama, 2008; Villalobos-Gallegos et al., 2017). 
However, it is important to note, that theoretical and practical con-
clusions, such as structure of psychopathology in the AUD population or 
assessment of specific treatment effects, can only cautiously be drawn 
from the present study due to its methodological limitations (e.g., lack 
of randomized controlled trial, follow-up data collection, examination 
of treatment moderators and mediators, potential self-selection bias of 
the participants, and inclusion of relevant confounding variables). 
2. Methods 
2.1. Participants and procedure 
The present study was conducted between 2013 and 2018 at the 
Nyírő Gyula National Institute of Psychiatry and Addictions, Budapest, 
Hungary. The study specifically focused on the MM treatment program 
which was primarily designed for patients with AUD or gambling pro-
blems. The treatment includes eight weeks of community-based re-
sidential care which harmonizes professional treatment approaches and 
principles of the twelve-step based self-help group of Alcoholics 
Anonymous (AA). In line with the concepts of AA, the treatment pri-
marily aims to aid patients to reach and maintain long-term abstinence. 
The treatment program emphasizes relevance of group-therapeutic 
context, community-based factors, and therapeutic effect of ‘here-and- 
now’ in AUD-related and psychological progress. Recovery of patients is 
followed and guided by a multidisciplinary staff team comprising pro-
fessional therapeutic specialists (i.e., clinical psychologist, psychiatrist, 
addictology-specific consultant), nurses and recovering helpers (i.e., 
individuals who have successfully recovered from addiction-specific 
problems and who provide counselling in an addiction-specific treat-
ment program; Doukas & Cullen, 2010). During the treatment, various 
group and individual psychotherapeutic techniques are applied, in-
cluding daily AA meetings, specific group meetings based on the the-
oretical and practical principles of AA, assertiveness training, relaxation 
and stress management training, teaching of effective coping and re-
lapse prevention skills, art therapeutic sessions, group meetings for 
affected family members, and psycho-education. The structure of the 
applied therapeutic techniques in the treatment program is presented in  
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Table 1, while short description of the main treatment forms is shown in  
Table 2. Each patient has an individual consultant from the staff team, 
therefore frequent and regular individual consultations also support 
and facilitate progression of the participants. The daily schedule of the 
therapeutic sessions and related assignments are controlled by time-
tables (see: Table 1) in addition to the predefined, eight-week long 
structure for the program. The first two weeks of the treatment are 
relatively restrictive (e.g., it is not allowed to leave the therapeutic site 
or to have visitors) which aims to gain a more self- and therapeutic- 
focused attention, while in subsequent weeks, amongst others, partici-
pation in daily AA meetings and twelve-step-related functions (e.g., 
selection of a sponsor) are emphasized to a greater degree. An adap-
tation period is held in the seventh week of the treatment. During this 
time, the participants stay at their home, which, for example, allow for 
them to monitor their experiences in their ordinary environment (for 
further details, see Tóth, 2018). Although the main therapeutic ap-
proaches and characteristics of the treatment program remained un-
changed from the beginning (e.g., structured organization and time-
table, main therapeutic sessions, requirements for enrollment), it is 
important to take into account that some changes might have affected 
treatment processes over time (e.g., development of therapeutic skills 
and expertise over time, changes in the staff). 
Overall, 303 inpatients (180 males and 123 females) with AUD 
participated in the present study. A total of 218 participants (71.95%) 
successfully completed the eight-week long program, while 85 in-
patients (28.05%) dropped out from the treatment before completion 
(see ‘Sample characteristics’ subsection). Every patient who were ad-
mitted to the treatment program between March 2013 and April 2018 
were included as a participant in the present study. Each of the at-
tending patients agreed (and provided informed consent) to participate 
Table 1 
General timetable for the treatment program.          
Time Monday Tuesday Wednesday Thursday Friday Saturday Sunday  
7:30–8:00 Morning thoughts Morning thoughts Morning thoughts Morning thoughts Morning 
thoughts 
Morning thoughts Morning 
thoughts 
8:00–8:30 – – – – – – – 
8:30–9:00 Just for today Just for today Just for today Just for today Just for today Breakfast 
9:00–9:30 Breakfast Breakfast Breakfast Breakfast Breakfast Breakfast Film group 
with 
discussion 9:30–10:00 Assertiveness training, or 
AA-steps group, or 
Psychoeducation 
Assertiveness training, or 
AA-steps group, or 
Psychoeducation 
Assertiveness training, or 
AA-steps group, or 
Psychoeducation 
Art therapeutic group Week ending 
group 
– 
10:00–10:30 Retrospective 
meeting for the 
week 10:30–11:00 Week starting group – – Film group 
with 
discussion 11:00–11:30 Assertiveness training, or 
AA-steps group, or 
Psychoeducation 
Full department group – – – 
11:30–12:00 – 
12:00–12:30 Lunch Lunch Lunch Lunch Lunch Lunch Lunch 
12:30–13:00 Film group with 
discussion 
13:00–13:30 Individual consultations 
and/or working on 
therapeutic tasks 
Individual consultations 
and/or working on 
therapeutic tasks 
Individual 
consultations and/or 
working on 
therapeutic tasks 
Group for 
affected family 
members 
Emotion-focused 
board game 
– 
13:30–14:00 
14:00–14.30 – 
14:30–15:00 – 
15:00–15:30 Working on therapeutic 
tasks 
Stress management 
training 
Stress management 
training 
– 
15:30–16:00 
16:00–16:30 – – – 
16:30–17:00 
17:00–17:30 AA meeting AA meeting AA meeting AA meeting AA meeting AA meeting 
17:30–18:00 
18:00–18:30 
18:30–19:00 
19:00–19:30 
19:30–20:00 
20:00–20:30 Dinner Dinner Dinner Dinner Dinner Dinner Dinner 
20:30–21:00 Evening thoughts Evening thoughts Evening thoughts Evening thoughts Evening 
thoughts 
Evening thoughts Welcome 
back meeting 
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in the study. Detoxification was undertaken prior to the participants’ 
enrolment in the program as it was required from them to have at least 
one-week long abstinence and show absence of physical and acute 
psychological withdrawal before starting the treatment program. An 
approximately one-hour long, semi-structured interview was adminis-
tered by the treatment staff before treatment enrollment. The interview 
took place at the treatment site, and an addition to the individual with 
AUD, one of his/her relatives also participated in the interview. The 
presence of the affected family members provides the opportunity to 
obtain a more accurate picture about the complex nature of problematic 
alcohol use not only for the staff but also for the individual with AUD 
(e.g., by asking them to share how the problematic alcohol use affected 
the function of the family). It also helps in observing possible psycho-
logical dynamics within the family, and motivates the relatives to 
participate in the treatment program (i.e., the group of affected family 
members). During the interview motivation for treatment and change in 
the problematic use of alcohol, as well as aspects of treatment contra-
indication, were evaluated. Lack of organic dementia, severe person-
ality disorder, tendency to act out, and acute suicide risk were pre-
requisites for treatment involvement. Moreover, data were collected 
during the interview concerning socio-demographics (e.g., age, gender, 
education, and work history), sources of family or social support, while 
psychiatric anamnesis was also evaluated (e.g., family history of sub-
stance misuse, previous suicide attempts, psychiatric-, AUD- or SUD- 
related treatment involvement history). The present study also assessed 
if a participant had received some forms of psychiatric-related or AUD- 
related pre-care shortly before the treatment program. Pre-care in-
volvement was considered if a participant was directed from an 
inpatient psychiatric- or AUD-related department to the MM treatment 
program, or reported a participation in a psychiatric-, AUD- or SUD- 
related treatment program within one month before the start of the MM 
program. Standardized questionnaires were used at two measurement 
points. On first entering the treatment program, alcohol consumption 
(e.g., harmful alcohol consumption, drinking motives), and psycho-
pathological-related aspects were assessed. At the end of the treatment 
program, the levels of psychopathological symptoms were re-assessed. 
Research assessment was conducted by the treatment staff at both 
measurement points. Among those participants who dropped out from 
the treatment before completion, data were only available at the first 
measurement point. Systematic follow-up data collection either after 
successful treatment completion or treatment interruption was not 
carried out. 
2.2. Measures 
2.2.1. Alcohol Use Disorders Identification Test (AUDIT) 
The 10-item AUDIT was used to assess the degree of harmful alcohol 
consumption and consequences (Saunders, Aasland, Babor, De La 
Fuente, & Grant, 1993; Hungarian version: Gerevich, Bácskai, & Rózsa, 
2006). Participants were assessed with the instrument before the be-
ginning of the treatment program. In line with the assumed uni-
dimensional structure of the scale (Skogen, Thørrisen, Olsen, Hesse, & 
Aas, 2019), total scale point was used for analyses. The scale had suf-
ficient internal consistency in the present sample (Cronbach’s 
α = 0.72). 
Table 2 
Main therapeutic forms of the treatment program.    
Name of the session Short description and examples  
Morning thoughts Group meeting which is guided by a trained nurse. Example session: a daily quote is selected, and participants are asked to think 
about how it can be related to their recovery. 
Evening thoughts Group meeting which is guided by a trained nurse. Example session: participants are asked to summarize and describe their day, 
daily emotions, etc. 
Just for today AA-specific group meeting which is guided by a recovering helper. The session follows theoretical and practical approaches of the 
AA. Example session: discussion of the experiences, questions of the participants regarding daily AA meetings and their process of 
recovery. 
Assertiveness training Relapse prevention-specific group session which is guided by a clinical psychologist. Example session: practicing how to handle and 
cope with situations when there is a risk for substance use. 
AA-steps group AA-specific group session which is guided by a recovering helper. It focuses on the first two steps of the AA. It is held between the 
third and sixth weeks. 
Psychoeducation Group meeting which is guided by a psychiatrist with the aim of facilitating knowledge about substance use disorder-related 
mechanisms. Example session: discussion of the main characteristics of substance use disorders, education about relevant 
psychological defense mechanisms. 
Week starting group Group meeting where all inpatients and staff team members are included. Community-based therapeutic approaches are applied in 
this group. Themes of the sessions are not pre-defined, and are typically determined by the inpatients. Example session: discussion 
of problems occurring during the weekend with family members. 
Week ending group Group meeting where all inpatients and staff team members are included. Community-based therapeutic approaches are applied in 
this group. Themes of the sessions are not pre-defined, and are typically determined by the inpatients. Example session: preparation 
for returning home and meeting with family members during the weekend. 
Full department meeting Group meeting where all inpatients and staff team members of the Department of Addictology are involved (i.e., not just from the 
Minnesota treatment program). Example session: discussing issues which affect therapeutic work of the Department of 
Addictology. 
Art therapeutic group Creative group meeting which is held by a clinical psychologist. Example session: participants are encouraged to present a given 
problematic psychological aspect of their life by drawing. 
Film group with discussion Participants watch films which are relevant in terms of substance misuse and recovery, which is either followed by a group 
discussion or participants are asked to summarize their thoughts and feelings, emotions about the movie in written form. 
Individual consultations Each patient has an individual consultant from the staff team, therefore frequent and regular individual consultations also support 
and facilitate progression of the participants. 
Working on therapeutic tasks Some therapeutic forms require participants to prepare therapeutic tasks or homework to facilitate progression. Example tasks: 
writing an autobiography, reading the Big Book of AA and about the twelve steps. 
Stress management training Group meeting which is held by a clinical psychologist. Relaxation and imaginative elements are included in this therapeutic form. 
Example session: teaching and practicing basic elements of autogenic training. 
Group for affected family members Group meeting where affected family members of the inpatients are included. The meetings’ focus is not on the patient but on 
providing support and opportunity for consultations for family members. Example session: discussing how the affected family 
members trying to cope with the individual showing problematic alcohol use. 
AA meeting Patients are required to participate in AA meetings on a daily basis. This therapeutic form is held outside of the treatment site. 
Therapeutic forms on Saturday and Sunday Patients are only required to stay on the treatment site on the first weekend of the treatment program. Therefore, the treatment 
forms presented in Table 1 on these days are not relevant on other weeks of treatment program. 
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2.2.2. Brief Symptom Inventory (BSI) 
The present study assessed psychopathological symptom severity 
using the 53-item BSI at the beginning and at the end of the treatment 
program (Derogatis & Savitz, 2000; Hungarian version: Unoka et al., 
2004). Previous research findings supported that the BSI was an ap-
propriate instrument to reflect on the hierarchical structure of psy-
chiatric symptoms by assessing general and specific factors of psycho-
pathology simultaneously (Urbán et al., 2014), therefore general 
symptom severity, anxiety, depression, hostility, interpersonal sensi-
tivity, obsessive-compulsive, paranoid ideation, phobic anxiety, psy-
choticism, and somatization scale scores were considered for analyses. 
The subscales of the BSI displayed acceptable levels of internal con-
sistency at both measurement points (pre-treatment: Cronbach’s 
α = 0.73–0.89; post-treatment: Cronbach’s α = 0.68–0.86). 
2.2.3. Drinking Motivations Questionnaire–Revised (DMQ-R) 
In order to assess the motives underlying drinking behavior, the 20- 
item DMQ-R was used at the beginning of the treatment program 
(Kuntsche, Knibbe, Gmel, & Engels, 2006; Hungarian version: Németh 
et al., 2011). The four subscales of the questionnaire (conformity, coping, 
enhancement, and social motives) provided satisfactory degree of internal 
consistency in the present sample (Cronbach’s α = 0.79–0.90). 
2.3. Data analysis 
Latent class growth analysis (LCGA) was used to identify subgroups 
of participants based on the evaluation of psychopathological symptom 
profiles and change trajectories (Jung & Wickrama, 2008). Average 
item scores of the BSI subscales assessed at the beginning and at the end 
of the treatment were specified as continuous indicator variables. Ac-
cording to the LCGA approach, within-class variances were set to zero. 
Starting with the most parsimonious, one-class solution, models with a 
growing number of latent classes were assessed during an iterative es-
timation process. The level of model fit was evaluated based on various 
indices. The most sufficient model should be characterized with lower 
rates of Akaike Information Criteria (AIC), Bayesian Information Cri-
teria (BIC), Sample Size Adjusted Bayesian Information Criteria (SSA- 
BIC), and higher level of entropy. More close fit to the data should be 
considered in case of a significant result of the Lo-Mendel-Rubin Ad-
justed Likelihood Ratio Test (LMRT) for a given model compared to the 
previous model with fewer latent classes. Pairwise missing data hand-
ling was used. Therefore, those who only had data at the first mea-
surement point only contributed to the estimation of parameters related 
to the beginning of the treatment, while parameters related to the end 
of the treatment were estimated based on only those participants’ re-
sponses who had data at the second measurement point (covariance 
coverage = 69.8–100%). 
Next, the identified latent classes were validated by analyzing their 
relationship with age, gender, family history of substance misuse, pre-
vious suicide attempt, psychiatric-, AUD-, or SUD-related pre-care be-
fore the treatment program, level of harmful alcohol consumption, 
drinking motives, and treatment reliability change index (RCI;  
Jacobson & Truax, 1992). The RCI provides a standardized assessment 
for each participant as to whether an individual change score is sta-
tistically significantly different from a difference that could have oc-
curred due to random measurement error alone. It considers the dif-
ference of the post- and pre-treatment score, which is divided by 
standard error of the differences (Ferguson, Robinson, & Splaine, 2002). 
It is important to note, that it does not inform whether a statistically 
significant change was caused by a particular intervention program. 
The validation analyses were carried out with multinomial logistic re-
gression (R3Step) and the Bolck-Croon-Hagenaars (BCH) method 
(Asparouhov & Muthen, 2013, 2014). Mplus 8.0 and SPSS Statistics 
25.0 statistical software were used to perform the analyses. 
3. Results 
3.1. Sample characteristics 
Sample characteristics are presented in Table 3. A higher proportion 
of the participants were male, reported a family history of SUD, and 
most of the respondents reported a psychiatric-related or AUD-related 
treatment engagement in their lifetime or shortly before the treatment 
program. Over two-thirds of the participants successfully completed the 
eight-week long MM program. Most frequently, the treatment was in-
terrupted because of alcohol consumption during the program, while 
other participants also reported about treatment-based reasons (e.g. 
ambivalence towards the aims and assignments of the program) non- 
treatment-based reasons (e.g. occupational, relationship, or adminis-
trative problems), or other or undefined reasons for treatment inter-
ruption (e.g. patient did not return to the program after weekend). 
3.2. Latent class growth analysis (LCGA) 
A latent class growth analysis (LCGA) was performed to identify 
latent classes based on distinct symptomatic profiles and to examine 
psychopathological symptom change trajectories. Models which con-
tained one to four latent classes were evaluated. Table 4 contains the fit 
indices for the LCGA models with different number of latent classes. 
The four-class solution presented the lowest rates of AIC, BIC and SSA- 
BIC. However, the LMRT showed a non-significant result (p  >  0.05) 
for the model with four latent classes. Therefore, the inclusion of an 
additional subgroup in the model over three latent classes did not 
Table 3 
Descriptive characteristics of the sample in terms of socio-demographics, psy-
chiatric anamnesis and treatment completion (N = 303).    
Sample characteristics  
Gender N (%)  
Females 123 (40.59%) 
Males 180 (59.41%) 
Age M (SD) 46.43 (10.32) 
Family history of substance misuse N (%) 
Yes 197 (65.02%) 
No 105 (34.65%) 
Previous suicide attempt N (%) 
Yes 58 (19.14%) 
No 244 (80.53%) 
Psychiatric-, AUD- or SUD-related treatment involvement history N (%) 
Yes 294 (97.03%) 
No 9 (2.97%) 
Psychiatric- or AUD-related pre-care within 1 months before the treatment program N 
(%) 
Yes 248 (81.85%) 
No 55 (18.15%)  
Treatment completion statistics 
Treatment completion status N (%) 
Successful treatment completion 218 (71.95%) 
Interruption of the treatment before completion 85 (28.05%) 
Reasons of treatment interruption N (%)  
Alcohol consumption 27 (31.76%) 
Treatment-based reasons1 20 (23.53%) 
Non-treatment-based reasons2 18 (21.18%) 
Other or undefined reasons3 20 (23.53%) 
Note. 1Treatment-based reasons: ambivalence towards the aims and assign-
ments of the program, non-completion of the assignments of the treatment, 
violation of treatment rules (e.g., use of mobile phone), acting out, feelings of 
doubt about the necessity of treatment, unable to work or open up in group 
psychotherapeutic sessions, reassignment to psychiatric inpatient department 
because of severe depressive symptoms, unable to continue treatment because 
of the circumstances in the treatment department. 2Non-treatment-based rea-
sons: occupational, relationship, or administrative problems. 3Other or un-
defined reasons: patient did not return to the program after weekend without 
notification, no available reason of treatment interruption.  
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contribute to a more optimal degree of model fit. For further analyses 
the three-class model was retained. In case of the three-class solution, 
the average latent class probabilities for the most likely latent class 
membership were 0.94, 0.96, and 0.98, respectively. 
Fig. 1 and Table 5 demonstrate the symptom profiles of the three 
identified latent classes at the beginning and the end of the treatment 
program. Apart from the change of hostility for Class 3, latent classes 
showed significant decreases in each dimension of psychopathological 
symptoms. Generally, within each latent class, participants experienced 
anxiety, depression, and obsessive-compulsive symptoms at the highest 
severity levels. Individuals assigned to Class 1 (“low severity sympto-
matic subgroup with mild decrease”) had low-severity symptom pro-
files at both measurement points. For example, at the beginning of the 
treatment period, a 43-year-old female patient who was a member of 
this class reported experiencing most frequently psychiatric symptoms 
“slightly” and “not at all”. At the end of the treatment, this patient was 
predominantly free of psychiatric symptoms. Individuals assigned to 
Class 2 (“moderate severity symptomatic subgroup with strong de-
crease”) had moderate levels of symptomatic severity at the beginning 
of the treatment, but low levels of symptomatic severity by the end of 
the program. For example, at the beginning of the treatment period, a 
47-year-old male patient who was a member of this class reported ex-
periencing most frequently symptoms of (i) anxiety, interpersonal 
sensitivity, obsessive-compulsivity, paranoid ideation, psychoticism 
and somatization “slightly” and “moderately”, (ii) phobic anxiety 
“moderately” and “fairly”, and (iii) depressive symptoms “fairly” and 
“extremely”. At the end of the treatment, this patent mostly reported 
experiencing psychiatric symptoms “slightly” and “not at all”. In-
dividuals assigned to Class 3 (“high severity symptomatic subgroup 
with moderate decrease”) had high levels of symptomatic severity at 
the beginning of the treatment program, but moderate levels of symp-
tomatic severity by the end of the program. For example, at the be-
ginning of the treatment period, a 59-year-old female patient who was a 
member of this class reported experiencing most frequently symptoms 
of (i) psychoticism “moderately” or “not at all”, (ii) anxiety, depression, 
hostility, interpersonal sensitivity, paranoid ideation and somatization 
“moderately” and “fairly”, and (iii) obsessive compulsivity “fairly” and 
“extremely”. At the end of the treatment this patient most frequently 
experienced symptoms of (i) hostility and psychoticism “not at all” and 
slightly”, (ii) anxiety, depression and paranoid ideation “slightly”, (iii) 
interpersonal sensitivity “slightly” and “moderately”, (iv) phobic an-
xiety “slightly” and “extremely”, (v) symptoms of obsessive-compul-
sivity “moderately”, and (vi) symptoms of somatization “fairly”. 
3.3. Validation of the latent classes 
The identified latent classes were contrasted in terms of alcohol 
consumption-related variables. Table 5 shows the results of the multiple 
comparisons. The “low severity” subgroup significantly demonstrated 
the lowest rates on alcohol consumption-related variables at the be-
ginning of the treatment program. The “moderate severity” and “high 
severity” subgroups significantly demonstrated higher levels of harmful 
alcohol consumption and drinking motives at the beginning of the 
treatment program. 
Next, multinomial logistic regression analysis was performed to 
examine the association between latent class membership and psycho-
pathological history-related and alcohol consumption-related covari-
ates (Table 6). The “low severity” subgroup was selected as the re-
ference category. The presence of family history of substance misuse, 
absence of pre-care before the treatment program, higher rates of 
coping drinking motives and harmful alcohol consumption all sig-
nificantly increased the odds of being in the “moderate severity” sub-
group membership compared to the reference category. In the case of 
the “high severity” subgroup, higher rates of conformity and coping 
drinking motives significantly contributed to the class membership 
compared to the reference category. 
In terms of the symptom change reliability index, individuals in the 
“moderate severity” subgroup significantly demonstrated the highest 
rates of reliable symptom decreases (Tables 5 and 7). Compared with 
members of the other classes, they showed the highest level of non- 
random measurement error-based symptom decrease (Table 5), and 
significantly higher proportion of this class was categorized with reli-
able symptom decrease (as opposed to non-reliable change or reliable 
increase of symptoms) compared to the “light severity” class. 
In terms of treatment completion, 24.7%, 27.4% and 38.3% treat-
ment attrition rates were presented for the “low severity”, “moderate 
severity” and “high severity” classes, respectively. There was a non- 
significant relationship between treatment completion status and latent 
class membership (Table 7). 
4. Discussion 
The present study aimed to identify subgroups of participants with 
AUD attending a twelve-step based treatment program based on psy-
chopathological symptom profiles and change trajectories. To the best 
of the authors’ knowledge, no previous study has examined how latent 
classes of AUD change during treatment attendance in terms of co-oc-
curring psychopathological symptom levels. Three latent classes were 
identified: (i) a low severity symptomatic subgroup at baseline with 
mild decrease, (ii) a moderate severity symptomatic subgroup at 
baseline with strong decrease, and (iii) a high severity symptomatic 
subgroup at baseline with moderate decrease. 
In line with some of the previous findings, quantitative differences 
were observed between the subgroups (Urbanoski et al., 2015; 
Villalobos-Gallegos et al., 2017). Namely, classes were separated by 
symptom profiles with intensifying severity at both measurement 
Table 4 
Fit indices for the latent class growth analysis models based on the scales of the 
Brief Symptom Inventory.          
AIC BIC SSA-BIC Entropy LMRT p  
1-class model  10618.05  10766.34  10639.48    
2-class model  8466.55  8692.68  8499.22  0.955  2175.36  < 0.001 
3-class model  7811.61  8115.59  7855.53  0.946  691.17 0.016 
4-class model  7386.42  7768.26  7441.60  0.935  463.32 0.403 
Note. AIC = Akaike Information Criteria; BIC = Bayesian Information Criteria; 
SSA-BIC = Sample Size Adjusted Bayesian Information Criteria; LMRT = Lo- 
Mendel-Rubin Adjusted Likelihood Ratio Test.  
Fig. 1. Mean item scores of the three latent classes on the subscales of the BSI 
before and after the treatment program. Abbreviations: GS = Global symptom 
severity, ANX = Anxiety; DEP = Depression; HOS = Hostility; 
IS = Interpersonal sensitivity; OC = Obsessive-compulsive; PAR = Paranoid 
ideation; PHO = Phobic anxiety; PSY = Psychoticism; SOM = Somatization. 
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points. However, it is important to note, the present study had limited 
assessment of externalizing characteristics (e.g., absence of antisocial 
personality disorder, drug misuse, etc.) which might have influenced 
characteristics of the latent classes. This data pattern also corresponds 
with the concept of hierarchical structure of psychopathology: a higher 
order dimension of internalizing psychopathology might explain the 
interrelations of psychopathological symptoms within each class and 
represent a severity-based risk for experienced psychopathological 
difficulties (Kotov et al., 2017; Villalobos-Gallegos et al., 2017). 
The identified latent class model is also comparable with previous 
studies using latent class analysis in treatment seeking or general po-
pulation samples of individuals with AUD. The “low severity” subgroup 
had comparable symptom profile to the “low comorbidity” AUD sub-
type by Müller et al. (2019), the “mild” class by Villalobos-Gallegos 
et al. (2017) or the “comorbidity unaffected” group by Glass et al. 
(2014). The “moderate severity” subgroup corresponded with the 
“moderate” class by Villalobos-Gallegos et al. (2017). Finally, the “high 
severity” subgroup presented similar characteristics to the “inter-
nalizing comorbidity” group by Glass et al. (2014), “multimorbidity” 
class by Urbanoski et al. (2015) or the “moderate/severe” class by  
Villalobos-Gallegos et al. (2017). 
The subgroups not only differed by severity of symptoms, but also 
showed different levels of symptomatic change during the eight-week 
long period. Symptom decrease with the largest and most reliable (non- 
measurement error-related) effect was demonstrated in the case of the 
“moderate severity” subgroup. The “low severity” and “high severity” 
subgroups demonstrated significant but less intensive attenuation in 
each of the psychopathological domains. However, it is important to 
highlight, that design of the present study (e.g., lack of randomized 
controlled trial) was unable to determine whether these patterns of 
symptomatic decrease were attributable to the effect of the Minnesota 
Model treatment. Therefore, it limits the possibility of linking the pre-
sent findings to previous twelve-step based treatment related research 
data which has demonstrated that attendance in these interventions can 
Table 5 
Comparisons of the latent classes in terms of alcohol-related variables.        
Class 1 
“Low severity symptomatic 
subgroups with mild decrease” 
N = 146; 48.5% 
Class 2 
“Moderate severity symptomatic 
subgroup with strong decrease” 
N = 106; 35.2% 
Class 3 
“High severity symptomatic 
subgroup with moderate decrease” 
N = 49; 16.2% 
Overall Wald test 
(p)  
Parameter estimates of LCGA 
Global symptom severity I (S) 0.57 (−0.22) 1.49 (−0.78) 1.90 (−0.41)  
Anxiety I (S) 0.67 (−0.20) 1.69 (−0.87) 2.22 (−0.41)  
Depression I (S) 0.86 (−0.45) 2.22 (−1.37) 2.60 (−0.76)  
Hostility I (S) 0.39 (−0.10) 0.97 (−0.46) 1.30 (−0.22)  
Interpersonal sensitivity I (S) 0.51 (−0.15) 1.58 (−0.76) 1.93 (−0.52)  
Obsessive compulsive I (S) 0.74 (−0.28) 1.69 (−0.79) 2.20 (−0.29)  
Paranoid ideation I (S) 0.57 (−0.22) 1.43 (−0.69) 1.92 (−0.46)  
Phobic anxiety I (S) 0.38 (−0.14) 1.17 (−0.57) 1.82 (−0.36)  
Psychoticism I (S) 0.37 (−0.11) 1.37 (−0.76) 1.74 (−0.36)  
Somatization I (S) 0.43 (−0.22) 1.04 (−0.59) 1.34 (−0.34)   
Comparisons 
Harmful alcohol consumption1 M (SE) −0.27 (0.09)b 0.22 (0.09)a 0.32 (0.15)a 20.93 (< 0.001) 
Conformity drinking motive1 M (SE) −0.23 (0.08)b 0.18 (0.13)a 0.34 (0.20)a 12.89 (0.002) 
Coping drinking motive1 M (SE) −0.40 (0.10)b 0.41 (0.09)a 0.29 (0.17)a 39.37 (< 0.001) 
Enhancement drinking motive1 M (SE) −0.23 (0.09)b 0.17 (0.10)a 0.37 (0.21)a 12.21 (0.002) 
Social drinking motive1 M (SE) −0.18 (0.09)b 0.18 (0.11)a 0.14 (0.20)a,b 6.94 (0.031) 
Reliable Change Index (RCI) – Global 
Symptom Severity2 M (SE) 
−1.90 (0.29)a −7.73 (0.59)b −2.83 (1.18)a 77.13 (< 0.001) 
Note. The presented parameter estimates of LCGA are intercepts (I) and slopes (S) in brackets. Except the change of Hostility for Class 3 (p = 0.177), mean slope 
estimates in each latent classes were significant at least p  <  0.05 level. In the case of comparisons, means (standard errors in brackets) in the same row that do not 
share subscripts differ at p  <  0.05 level. BCH method was used in the comparison (Asparouhov and Muthén 2014). 1Variables measured at pre-treatment and 
standardized (variables’ mean equals to 0 and standard deviation equals to 1) in order to ease interpreation.2Lower values represent more reliable symptom decrease 
in terms of global psychopathological severity.  
Table 6 
Odds ratios (95% Confidence Intervals) of the association between validating covariates and latent class membership relative Class 1 (“Low severe symptomatic 
subgroups with mild decrease”).      
Class 2 
“Moderate severity symptomatic subgroup with 
strong decrease” 
N = 105; 34.9% 
OR [95% CI] 
Class 3 
“High severity symptomatic subgroup with 
moderate decrease” 
N = 49; 16.2% 
OR [95% CI]  
Age 1.01 [0.98 – 1.05] 1.02 [0.97 – 1.08] 
Gender1 1.36 [0.66 – 2.82] 1.99 [0.75 – 5.29] 
Family history of substance misuse2 2.13 [1.04 – 4.33] 2.25 [0.91 – 5.58] 
Previous suicide attempt2 1.39 [0.60 – 3.19] 1.75 [0.66 – 4.67] 
Psychiatric-, AUD- or SUD-related pre-care shortly before the 
treatment program 2 
0.36 [0.14 – 0.90] 0.35 [0.11 – 1.13] 
Harmful alcohol consumption 1.48 [1.00 – 2.19] 1.31 [0.72 – 2.38] 
Conformity drinking motive 1.50 [0.93 – 2.40] 1.81 [1.06 – 3.08] 
Coping drinking motive 2.53 [1.65 – 3.88] 1.85 [1.03 – 3.31] 
Enhancement drinking motive 1.10 [0.70 – 1.72] 1.36 [0.64 – 2.91] 
Social drinking motive 1.19 [0.74 – 1.92] 1.65 [0.79 – 3.46] 
Note. Odds ratios presented by bold figures are significant at least p  <  0.05 level. 1Gender: 0 = Female, 1 = Male; 2Categorical variables coded as 0 = No, 1 = Yes.  
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lead to attenuation of psychopathological symptoms (e.g., depression 
symptoms; Worley et al., 2012). However, by using a latent class-based 
approach it was possible to examine more specifically if different sub-
groups of AUD demonstrated different trajectories in terms of psycho-
pathological symptom reductions (Lanza & Rhoades, 2013). 
The present study also explored the association between latent class 
membership and alcohol consumption-related variables. Participants in 
the moderate and high severity symptomatic subgroups presented sig-
nificantly higher rates of baseline harmful alcohol consumption. These 
findings are consistent with previous empirical research which have 
demonstrated that some subgroups of AUD with increased severity of 
alcohol misuse are also characterized with more serious internalizing 
and externalizing symptoms (Hildebrandt et al., 2017; Moss et al., 
2010). Additionally, multivariate analyses identified the substantial 
role of baseline coping and conformity motives in the cases of the more 
severely affected classes. Both coping and conformity motives have 
been described as negative reinforcement-based motives of drinking 
which are implicated in self-medication tendencies of the participants. 
Regarding the coping motives, it was assumed that that alcohol con-
sumption serves as a form of emotion regulation among patients with a 
higher severity symptomatic level, which helps individuals mitigate and 
cope with unpleasant feelings and emotions (Berking et al., 2011). 
Previous studies have also demonstrated that subtypes of AUD with 
elevated internalizing symptomatology show increased rates of 
drinking in order to relief or self-medicate psychological distress 
(Hildebrandt et al., 2017; Müller et al., 2019). In the case of conformity 
motives, it was hypothesized that the “high severity” symptomatic class 
might show tendencies also to use alcohol as a means for reducing 
symptoms related to social anxiety (Villarosa, Madson, Zeigler-Hill, 
Noble, & Mohn, 2014). 
4.1. Limitations 
The present findings should be interpreted cautiously due to several 
limitations related to the study. First, the lack of control comparison 
group impeded to accurately interpret the efficacy of the MM in terms 
of psychopathological symptom reduction. Second, due to the absence 
of follow-up data collection, the present design did not assess the long- 
term alcohol use-related and psychopathological-related outcomes 
among the participants who successfully completed the program and 
among those who dropped out from it. Third, the present study did not 
examine the role of potential third variables which might have medi-
ated or moderated the treatment effect (e.g., AA involvement, comorbid 
psychiatric diagnosis). Fourth, it is important to consider that the 
composition of the present sample was based on availability of the 
patients, therefore the generalizability of the results to a broader po-
pulation with AUD is arguably limited. For example, findings from the 
National Epidemiologic Survey on Alcohol and Related Conditions 
(NESARC) and a nationally representative sample from Hungary have 
both shown that the lifetime treatment rates for AUD among those with 
AUD and in the latent class of ‘Alcohol drinkers with severe dependence 
symptoms’ are much lower than those in the present sample (Hasin & 
Grant, 2015; Horváth et al., 2019). As the applied treatment form was 
highly-structured and built upon the principles of the twelve-step ap-
proach, it might contribute to a self-selection effect of more motivated 
patients with a history of psychiatric treatment involvement. Fifth, as 
the research assessment was conducted by the treatment staff, it might 
had some effect on the participants’ response tendencies, in addition to 
the possible bias in responses due to the participation of affected family 
members in the admission interview. Sixth, design of the present study 
did not allow to analyze the causal relationship between AUD and 
psychopathological symptoms. Finally, the effects of important cov-
ariates were not controlled during the analyses which might have in-
fluenced profile characteristics and changed trajectories of psycho-
pathological symptoms, such as effects of detoxification in the first 
weeks of the treatment and potential period effects related to changes in 
therapeutic characteristics over the five-year period of the study. 
5. Conclusions 
The present study examined psychopathological symptom profiles 
and change trajectories among patients undergoing a twelve-step based 
MM treatment. The present study identified three severity-based sub-
groups of inpatients with AUD undergoing MM treatment. During the 
eight-week long period of the study, each of the three AUD severity 
classes demonstrated significant reductions in terms of psychopatho-
logical symptoms. Further studies, with more precise methodological 
design, are warranted to provide evidence whether structured, more 
intensive, and community-based residential treatment forms that fa-
cilitate twelve-step involvement can contribute to beneficial outcomes 
among AUD patients with more severe psychopathological sympto-
matic profiles (Karriker-Jaffe, Klinger, Witbrodt, & Kaskutas, 2018). 
Previous studies have suggested that integrated treatment forms, which 
simultaneously address AUD-related and psychological-related impair-
ments might have beneficial effects among patients with comorbid AUD 
and psychiatric disorders (McClean, Anspikian, Winters, & Tsuang, 
Table 7 
Association between treatment completion status, reliable change index categories and latent class membership.       
Class 1 
“Low severity symptomatic subgroups 
with mild decrease” 
N = 146; 48.5% 
Class 2 
“Moderate severity symptomatic subgroup 
with strong decrease” 
N = 106; 35.2% 
Class 3 
“High severity symptomatic subgroup with 
moderate decrease” 
N = 49; 16.2%  
Treatment completion status 
Successfully completed treatment;  
N = 218 (71.9%) 
110 (75.3%) 77 (72.6%) 30 (61.2%) 
Dropped from treatment; N = 85 
(28.1%) 
36 (24.7%) 29 (27.4%) 19 (38.3%) 
OR [95% CI]* - Successful completion Ref. 0.87 [0.49–1.54] 0.52 [0.26–1.03]  
Categories of Reliable Change Index (Global symptom severity) 
Reliable decrease of symptoms N = 134 
(63.8%) 
50 (47.2%) 66 (88.0%) 18 (62.1%) 
Non-reliable change N = 59 (28.1%) 49 (46.2%) 5 (6.7%) 5 (17.2%) 
Reliable increase of symptoms N = 17 
(8.1%) 
7 (6.6%) 4 (5.3%) 6 (20.7%) 
OR [95% CI]* - Reliable decrease Ref. 8.21 [3.71–18.17] 1.83 [0.79–4.25] 
Note. Percentages in each cells represents the proportion within each latent classes. Treatment completion status: χ2(2) = 3.66; p = 0.160. Categories of Reliable 
Change Index: χ2(4) = 44.05; p  <  0.001. OR: odds ratio. CI: confidence interval. *Comparison group is Class 1 (Ref. = reference group). A dichotomous outcome 
variable was constructed for comparisons: 0 = Non-reliable change or reliable increase of symptoms, 1 = Reliable decrease of symptoms. OR presented with bold 
figures are significant at least p  <  0.05 level.  
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2014). Interventions which combined treatment approaches focusing 
on AUD and co-occurring psychiatric disorders were used to facilitate 
simultaneous improvements in symptomatology of AUD as well as co-
morbid disorders. For example, in the cases of comorbid AUD and in-
ternalizing psychiatric disorders, one might consider teaching effective 
coping and emotion-regulation strategies to control negative emotions. 
This includes cognitive restructuring techniques to explore and correct 
situational and cognitive risk processes (e.g., beliefs) underlying AUD 
and comorbid internalizing disorders (e.g., anxiety, depression dis-
orders), and understanding and altering expectancies and motivational 
processes of alcohol use which can be associated with symptoms of 
negative affectivity (Morris, Stewart, & Ham, 2005; Roberts et al., 
2015). 
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